234 related articles for article (PubMed ID: 23369537)
1. Syntheses of lipophilic chalcones and their conformationally restricted analogues as antitubercular agents.
Ahmad I; Thakur JP; Chanda D; Saikia D; Khan F; Dixit S; Kumar A; Konwar R; Negi AS; Gupta A
Bioorg Med Chem Lett; 2013 Mar; 23(5):1322-5. PubMed ID: 23369537
[TBL] [Abstract][Full Text] [Related]
2. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
[TBL] [Abstract][Full Text] [Related]
3. 1-Chloro-2-formyl indenes and tetralenes as antitubercular agents.
Chanda D; Saikia D; Kumar JK; Thakur JP; Agarwal J; Chanotiya CS; Shanker K; Negi AS
Bioorg Med Chem Lett; 2011 Jul; 21(13):3966-9. PubMed ID: 21641212
[TBL] [Abstract][Full Text] [Related]
4. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
[TBL] [Abstract][Full Text] [Related]
6. Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis.
Ramesh D; Joji A; Vijayakumar BG; Sethumadhavan A; Mani M; Kannan T
Eur J Med Chem; 2020 Jul; 198():112358. PubMed ID: 32361610
[TBL] [Abstract][Full Text] [Related]
7. Enantiopure antituberculosis candidates synthesized from (-)-fenchone.
Dobrikov GM; Valcheva V; Nikolova Y; Ugrinova I; Pasheva E; Dimitrov V
Eur J Med Chem; 2014 Apr; 77():243-7. PubMed ID: 24642567
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antimalarial and antitubercular activity of acetylenic chalcones.
Hans RH; Guantai EM; Lategan C; Smith PJ; Wan B; Franzblau SG; Gut J; Rosenthal PJ; Chibale K
Bioorg Med Chem Lett; 2010 Feb; 20(3):942-4. PubMed ID: 20045640
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
Ali MA; Yar MS; Kumar M; Pandian GS
Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates.
Onajole OK; Govender P; van Helden PD; Kruger HG; Maguire GE; Wiid I; Govender T
Eur J Med Chem; 2010 May; 45(5):2075-9. PubMed ID: 20149497
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of some new 1,4-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents.
Khoshneviszadeh M; Edraki N; Javidnia K; Alborzi A; Pourabbas B; Mardaneh J; Miri R
Bioorg Med Chem; 2009 Feb; 17(4):1579-86. PubMed ID: 19162489
[TBL] [Abstract][Full Text] [Related]
12. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
14. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
[TBL] [Abstract][Full Text] [Related]
15. Substituted quinolinyl chalcones and quinolinyl pyrimidines as a new class of anti-infective agents.
Sharma M; Chaturvedi V; Manju YK; Bhatnagar S; Srivastava K; Puri SK; Chauhan PM
Eur J Med Chem; 2009 May; 44(5):2081-91. PubMed ID: 19028410
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives.
Ali MA; Shaharyar M; Siddiqui AA
Eur J Med Chem; 2007 Feb; 42(2):268-75. PubMed ID: 17007966
[TBL] [Abstract][Full Text] [Related]
17. New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity.
Castaño LF; Cuartas V; Bernal A; Insuasty A; Guzman J; Vidal O; Rubio V; Puerto G; Lukáč P; Vimberg V; Balíková-Novtoná G; Vannucci L; Janata J; Quiroga J; Abonia R; Nogueras M; Cobo J; Insuasty B
Eur J Med Chem; 2019 Aug; 176():50-60. PubMed ID: 31096118
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitubercular activity evaluation of novel unsymmetrical cyclohexane-1,2-diamine derivatives.
Beena ; Joshi S; Kumar N; Kidwai S; Singh R; Rawat DS
Arch Pharm (Weinheim); 2012 Nov; 345(11):896-901. PubMed ID: 22945019
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea.
Sriram D; Yogeeswari P; Madhu K
Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302
[TBL] [Abstract][Full Text] [Related]
20. Theophylline-7-acetic acid derivatives with amino acids as anti-tuberculosis agents.
Voynikov Y; Valcheva V; Momekov G; Peikov P; Stavrakov G
Bioorg Med Chem Lett; 2014 Jul; 24(14):3043-5. PubMed ID: 24878196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
